Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
dementia
Biotech
Takeda tears up Denali partnership, returning dementia asset
With DNL593 back in Denali's control, the biotech has no further collaborations ongoing with the Japanese pharma.
Darren Incorvaia
Apr 6, 2026 1:50pm
Voyager sets sail on neuro research trek with Transition Bio
Nov 10, 2025 5:23pm
Alector halves staff after GSK-partnered antibody fails in ph. 3
Oct 22, 2025 11:23am
Pharma-backed dementia fund raises $269M to invest in therapies
May 20, 2025 9:48am
Large trial reveals link between lowered BP and dementia risk
Apr 24, 2025 11:33am
GSK seeks link between shingles vax and lower dementia risk
Mar 25, 2025 5:00am
